コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nine vasopressin, agouti-related protein and alpha-melanocyte stimulating hormone.
2 examined how these responses are affected by alpha-melanocyte-stimulating hormone.
3 production but this response was reduced by alpha-melanocyte-stimulating hormone.
4 hat the levels were increased in response to alpha-melanocyte-stimulating hormone.
5 cts were found to be enhanced by addition of alpha-melanocyte-stimulating hormone.
6 abated the positive effects of [Nle, D-Phe]-alpha-melanocyte-stimulating hormone.
7 as glucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone.
8 detectable levels of adrenocorticotropin or alpha-melanocyte-stimulating hormone.
9 tions on stimulation with its natural ligand alpha-melanocyte-stimulating hormone.
11 cy of (188)Re-(Arg(11))[Cys(3,4,10),d-Phe(7)]alpha-melanocyte-stimulating hormone(3-13) (CCMSH) in th
12 ,8 tetrahydrobiopterin resulting in a stable alpha-melanocyte stimulating hormone/6(R)-L-erythro 5,6,
13 ojic acid, and niacinamide) and stimulators (alpha-melanocyte-stimulating hormone, 8-methoxypsoralen,
15 e inhibitor of rac1 abrogated the ability of alpha-melanocyte stimulating hormone, a peptide hormone
17 vity of the melanotropin peptides alpha-MSH (alpha-melanocyte-stimulating hormone, Ac-Ser-Tyr-Met-Glu
18 sion this study provides further evidence of alpha-melanocyte stimulating hormone acting to "protect"
19 on is similar in these two species homologs (alpha-melanocyte-stimulating hormone = adrenocorticotrop
20 For this purpose antibodies against alpha-melanocyte stimulating hormone, adrenocorticotropi
22 further evaluation of PDE4is with or without alpha-melanocyte-stimulating hormone agonists in vitilig
23 effects of two melanocortin system ligands, alpha melanocyte stimulating hormone (alpha-MSH) and ago
24 Within the ARC, IRS-2 was co-localized with alpha melanocyte stimulating hormone (alpha-MSH) as well
25 under both direct and indirect regulation by alpha melanocyte-stimulating hormone (alpha-MSH)-synthes
29 cotropic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are syn
30 Both forms act as competitive antagonists of alpha-melanocyte stimulating hormone (alpha-MSH) at mela
31 etermine whether the neuroprotective peptide alpha-melanocyte stimulating hormone (alpha-MSH) attenua
33 te the potential application of neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) in miti
34 te nucleus (ARC), and on opioid peptides and alpha-melanocyte stimulating hormone (alpha-MSH) in the
35 ne-regulated transcript (CART) coexists with alpha-melanocyte stimulating hormone (alpha-MSH) in the
40 opiomelanocortin (POMC)-derived neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is know
42 chanisms underlying the effects of intra-VTA alpha-melanocyte stimulating hormone (alpha-MSH) on feed
43 ed and compared with four other radiolabeled alpha-melanocyte stimulating hormone (alpha-MSH) peptide
44 rg-X-Asp-conjugated and X-Ala-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptide
45 of new (99m)Tc-labeled Arg-X-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptide
46 elanoma prevention based on using analogs of alpha-melanocyte stimulating hormone (alpha-MSH) that fu
49 acrophage chemoattractant protein-1 (MCP-1), alpha-melanocyte stimulating hormone (alpha-MSH), and pe
50 -DOTA-ReCCMSH(Arg(11)), a cyclic analogue of alpha-melanocyte stimulating hormone (alpha-MSH), exhibi
51 ng factor (CRF) might be mediated via MC4-R. alpha-Melanocyte stimulating hormone (alpha-MSH), the MC
52 ncreasing the production of the MC4R ligand, alpha-melanocyte stimulating hormone (alpha-MSH), to reg
53 ach, MC4-R agonists, melanotan-II (MT-II) or alpha-melanocyte stimulating hormone (alpha-MSH), were u
57 or cells was blocked by co-administration of alpha-melanocyte stimulating hormone (alpha-MSH, 20 ng),
58 nal activity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and th
59 whether the functional IL-1beta antagonist, alpha-melanocyte-stimulating hormone (alpha-MSH(1-13)),
60 odistribution, and clearance kinetics of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog
62 We report in vitro and in vivo data of new alpha-melanocyte-stimulating hormone (alpha-MSH) analogu
63 de Y (NPY) and anorexigenic peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) and ano
64 ssessed plasma and cerebrospinal fluid (CSF) alpha-melanocyte-stimulating hormone (alpha-MSH) and bet
65 ression, resulting in selective increases of alpha-melanocyte-stimulating hormone (alpha-Msh) and car
66 G protein-coupled receptor (GPCR) that binds alpha-melanocyte-stimulating hormone (alpha-MSH) and has
69 These proteins antagonize the effects of alpha-melanocyte-stimulating hormone (alpha-MSH) and oth
70 opposing effects of the anorexigenic agonist alpha-melanocyte-stimulating hormone (alpha-MSH) and the
73 food intake and PK2 increased the release of alpha-melanocyte-stimulating hormone (alpha-MSH) from ex
74 nvestigated the efficacy of the neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) in prom
75 -clamp recordings revealed that both NPY and alpha-melanocyte-stimulating hormone (alpha-MSH) inhibit
80 state, the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is redu
81 in (ACTH) of pars distalis corticotropes and alpha-melanocyte-stimulating hormone (alpha-MSH) of pars
82 This study aimed at revealing the role of alpha-melanocyte-stimulating hormone (alpha-MSH) on baso
83 esize melanocortin receptor agonists such as alpha-melanocyte-stimulating hormone (alpha-MSH) or anta
84 e of the radiolabeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
85 termine whether (99m)Tc- and (111)In-labeled alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
86 ating phage that displayed up to 5 copies of alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
87 (POMC) neurons and the POMC-derived peptide alpha-melanocyte-stimulating hormone (alpha-MSH) promote
88 cortin type 1 receptor (MC1R), also known as alpha-melanocyte-stimulating hormone (alpha-MSH) recepto
90 mentation (suntanning) requires induction of alpha-melanocyte-stimulating hormone (alpha-MSH) secreti
94 nzyme prolylcarboxypeptidase (PRCP) degrades alpha-melanocyte-stimulating hormone (alpha-MSH) to an i
95 ow coat color by antagonizing the binding of alpha-melanocyte-stimulating hormone (alpha-MSH) to the
96 nucleus of the hypothalamus (PVN), to block alpha-melanocyte-stimulating hormone (alpha-MSH) type 3
97 for MC1R, inhibiting the alpha-melanocortin (alpha-melanocyte-stimulating hormone (alpha-MSH))-induce
98 for melanocortin 4 (MC-4) receptors such as alpha-melanocyte-stimulating hormone (alpha-MSH), a prod
99 volved in the regulation of feeding by using alpha-melanocyte-stimulating hormone (alpha-MSH), an end
100 ',N'''-tetraacetic acid), a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), has th
101 amus and regulating release of products like alpha-melanocyte-stimulating hormone (alpha-MSH), neurop
102 NPY) are potent appetite stimulants, whereas alpha-melanocyte-stimulating hormone (alpha-MSH), neurot
103 s of either a melanocortin receptor agonist, alpha-melanocyte-stimulating hormone (alpha-MSH), or ant
104 a-MSH (NDP-MSH), a highly potent analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), posses
105 dy was designed to examine the evidence that alpha-melanocyte-stimulating hormone (alpha-MSH), which
106 -amino group of Lys(10) of the cyclic lactam alpha-melanocyte-stimulating hormone (alpha-MSH)-derived
112 anogenesis through which ultraviolet (UV) or alpha-melanocyte-stimulating hormones (alpha-MSH) stimul
113 ere blocked by 2 different IL-1 antagonists, alpha melanocyte stimulating hormone (alphaMSH) and inte
115 trate that physiological melanogenic stimuli alpha-melanocyte stimulating hormone (alphaMSH) increase
117 wever, melanoma cells synthesize and release alpha-melanocyte stimulating hormone (alphaMSH, the liga
118 The behavior of these cells is influenced by alpha-melanocyte-stimulating hormone (alphaMSH) and mela
120 Interestingly, hypothalamic Pomc mRNA and alpha-melanocyte-stimulating hormone (alphaMSH) peptide
122 ibits the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, b
123 al, which can be achieved using radiolabeled alpha-melanocyte-stimulating hormone analog NAPamide der
125 stitutions did not affect the ability of the alpha-melanocyte stimulating hormone analogue [Nle4,D-Ph
127 We evaluated the safety and efficacy of an alpha-melanocyte-stimulating hormone analogue, afamelano
129 nduce dendrite formation in B16F1 cells, and alpha-melanocyte stimulating hormone and ultraviolet lig
130 that rac1 mediates the well-known ability of alpha-melanocyte stimulating hormone and ultraviolet lig
133 in; the proopiomelanocortin-derived peptides alpha-melanocyte-stimulating hormone and beta-endorphin,
135 n or contraction in melanocytes, mediated by alpha-melanocyte-stimulating hormone and melanin-concent
136 alpha, and of the anti-inflammatory peptides alpha-melanocyte-stimulating hormone and melanocyte-stim
137 marrow-derived macrophages, we observed that alpha-melanocyte-stimulating hormone and selective MC1-R
138 s spectra of the model peptides (bradykinin, alpha-melanocyte stimulating hormone, and melittin) chan
139 ro-opiomelanocortin (POMC)-derived peptides, alpha-melanocyte-stimulating hormone, and adrenocorticot
140 f dynorphin A-17, a decrease in the level of alpha-melanocyte-stimulating hormone, and an alteration
141 c gene encodes both the anorexigenic peptide alpha-melanocyte-stimulating hormone, and the opioid pep
142 dy was to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinfl
143 vasion and that the anti-invasive actions of alpha-melanocyte stimulating hormone are consistent with
145 tropic hormone, beta-lipotropic hormone, and alpha-melanocyte-stimulating hormone are also derived.
146 ls of stochastic carcinogenesis and identify alpha-melanocyte-stimulating hormone as a potential atte
148 effects through the blockade of signaling by alpha-melanocyte-stimulating hormone at central nervous
149 finity and potency of the endogenous agonist alpha-melanocyte-stimulating hormone at the MC4R by 37-
152 loudman S-91 mouse melanoma cells respond to alpha-melanocyte-stimulating hormone) by demonstrating a
155 to the cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP sign
156 (99m)Tc(CO)3-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone derivative, betaAla
157 tide that inhibits the binding and action of alpha-melanocyte-stimulating hormone derived from proopi
161 eptides (dynorphin A-17, beta-endorphin, and alpha- melanocyte-stimulating hormone) involved in the c
162 its production by melanocytes in response to alpha-melanocyte-stimulating hormone is associated with
165 d integrin expression and ask to what extent alpha-melanocyte stimulating hormone might protect cells
166 ts of two intercellular signaling molecules, alpha-melanocyte stimulating hormone (MSH) and agouti si
167 or induces activation of regulatory T cells, alpha-melanocyte stimulating hormone (MSH) and transform
168 Pigmentation in mammals is stimulated by alpha-melanocyte stimulating hormone (MSH), which binds
169 on of two intercellular signaling molecules, alpha-melanocyte-stimulating hormone (MSH) and agouti si
170 which may mediate the hypophagic effects of alpha-melanocyte-stimulating hormone (MSH) in the rat.
171 sthetized rats, unilateral microinjection of alpha-melanocyte-stimulating hormone (MSH) into the medu
175 the complete loss of both [Nle(4)-d-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) binding a
176 cture-activity studies of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) identifie
177 ic agouti-related protein (AGRP)/[Nle4,DPhe7]alpha-melanocyte stimulating hormone (NDP-MSH) ligands i
178 the protective effect of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH), a potent
180 d using assays for agonist, [Nle(4)-d-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) or
181 sm of human MC4R activation by [Nle4, d-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH), by first
182 ope of neuropeptide glutamic acid-isoleucine/alpha-melanocyte-stimulating hormone (NEI/alphaMSH) pept
184 d been grown in the presence of 10-11-10-9 M alpha-melanocyte-stimulating hormone prior to stimulatio
185 through actions on TRH neurons, addition of alpha-melanocyte-stimulating hormone produced a 3.5-fold
186 ion of the expression of proopiomelanocortin/alpha-melanocyte-stimulating hormone, provoked by C75 an
187 y pathologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utili
189 s corticotropin-releasing factor, leptin and alpha-melanocyte stimulating hormone regulate cytokine b
191 othalamic explants but significantly reduced alpha melanocyte stimulating hormone release in vitro.
192 temperature just before light onset, whereas alpha-melanocyte stimulating hormone release, especially
193 selectively increases beta-endorphin but not alpha-melanocyte-stimulating hormone release in the hypo
194 or in mediating immunomodulatory actions of alpha-melanocyte-stimulating hormone remains to be seen.
195 patibility complex class I and downregulated alpha-melanocyte-stimulating hormone, signifying immune
196 rs with the melanocortin analog [Nle, D-Phe]-alpha-melanocyte-stimulating hormone (starting 3 or 6 hr
197 h as endothelin 1, hepatocyte growth factor, alpha-melanocyte stimulating hormone, stem cell factor,
199 preputial glands of rodents is regulated by alpha-melanocyte stimulating hormone, the major agonist
200 ared with the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocorti
201 by Western immunoblotting and the ability of alpha-melanocyte stimulating hormone to oppose the actio
204 ction of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h af
205 ease in cAMP in response to stimulation with alpha-melanocyte-stimulating hormone was measured in HEK
206 by elevating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to ha
207 or and appear to be physiological targets of alpha-melanocyte-stimulating hormone, which inhibits foo
208 es, and tumorigenicity assays indicates that alpha-melanocyte-stimulating hormone, which is overprodu
209 y, which aims to maintain high urine output; alpha-melanocyte-stimulating hormone, with anti-inflamma
210 edulla and in a subset of cells coexpressing alpha-melanocyte-stimulating hormone within the pituitar